Contemporary analysis of ETEST for antibiotic susceptibility and minimum inhibitory concentration agreement against Pseudomonas aeruginosa from patients with cystic fibrosis

Evaluation of the Etest and disk diffusion method for detection of the activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa in China

(2020) Qi Wang et al.   BMC MICROBIOLOGY

Analysis of the susceptibility to ceftazidime/avibactam in German MDR/XDR Pseudomonas aeruginosa comparing different methods

(2019) Frieder Schaumburg et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Meropenem time above the MIC exposure is predictive of response in cystic fibrosis children with acute pulmonary exacerbations

(2018) Joseph L. Kuti et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Multicenter evaluation of the ETEST® gradient diffusion method for ceftolozane-tazobactam susceptibility testing of Enterobacteriaceae and Pseudomonas aeruginosa

(2018) Adam L. Bailey et al.   JOURNAL OF CLINICAL MICROBIOLOGY

CLSI Methods Development and Standardization Working Group Best Practices for Evaluation of Antimicrobial Susceptibility Tests

(2018) Romney M. Humphries et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Performance of the Etest for Susceptibility Testing of Enterobacterales (Enterobacteriaceae) and Pseudomonas aeruginosa toward Ceftazidime-Avibactam

(2018) Michael Kresken et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Use of ceftazidime/avibactam for the treatment of MDR Pseudomonas aeruginosa and Burkholderia cepacia complex infections in cystic fibrosis: a case series

(2018) G Spoletini et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Relevance of multidrug-resistant Pseudomonas aeruginosa infections in cystic fibrosis

(2017) S. Stefani et al.   INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY

Population Pharmacokinetics and Safety of Ceftolozane-Tazobactam in Adult Cystic Fibrosis Patients Admitted with Acute Pulmonary Exacerbation

(2016) Marguerite L. Monogue et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Susceptibility Testing Manufacturers Association Presents an Opinion for the Delay of Current Susceptibility Tests

(2016) Susan M. Kircher et al.   CLINICAL INFECTIOUS DISEASES

Cystic fibrosis

(2016) J Stuart Elborn   LANCET

Background and Epidemiology

(2016) Don B. Sanders et al.   PEDIATRIC CLINICS OF NORTH AMERICA

Pseudomonas aeruginosa Phenotypes Associated With Eradication Failure in Children With Cystic Fibrosis

(2014) Nicole Mayer-Hamblett et al.   CLINICAL INFECTIOUS DISEASES

Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008

(2010) Julia Emerson et al.   PEDIATRIC PULMONOLOGY